FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Loneliness and social isolation linked to heightened risk of death in those with cancer

2.

Is Exercise an Effective Treatment for Prostate Cancer?

3.

The self-sacrificing nature of breast cancer cells has been identified as a possible reason for relapse.

4.

According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.

5.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot